This study is close for enrollment. If you want to be contacted for similar studies, you can email us at tccr@tulane.edu or join our Volunteer Research Registry using the link below:
This NIH-funded study tests whether inhaled budesonide and formoterol can prevent acute respiratory failure (ARF). Though FDA-approved for asthma and COPD, their use for ARF is investigational. The drugs are considered safe, but their effectiveness for ARF prevention is unknown.
This study is exploring whether doxycycline, a common antibiotic, can help slow down lung damage from emphysema in people living with HIV. While doxycycline is FDA-approved for other conditions, its use in treating emphysema in this population is investigational. The trial also examines how safe and well-tolerated the drug is over time.
This study looks at how the immune system reacts to common food allergens like peanuts, tree nuts, milk, and eggs. By analyzing blood samples from people with and without food allergies, researchers hope to understand why some people have severe reactions and how food processing affects those responses. The goal is to improve allergy diagnosis and treatment.
This study explores how diabetes affects the body’s mineral balance—something that hasn’t been well understood. Researchers are especially focused on a type of diabetes drug (SGLT2 inhibitors) that helps with blood sugar and heart health but may cause unusual side effects.
This study is testing whether using a special surgical mesh called Phasix™ can help prevent hernias after abdominal surgery. Patients who have open abdominal surgery (a midline laparotomy) are randomly assigned to receive either the mesh or the standard method of closing the incision with stitches. The goal is to see if the mesh provides better support and reduces the chances of a hernia forming after surgery.
This study is on pause. If you want to be contacted for similar studies, you can email us at tccr@tulane.edu or join our Volunteer Research Registry using the link below:
The CHAP Child study investigates the long-term neurodevelopment and growth of children born to mothers with mild chronic hypertension (CHTN) who received early antihypertensive therapy compared to those who received no treatment until severe hypertension occurred. The study's purpose is to address the knowledge gap regarding the safety of early treatment for maternal CHTN and its effects on the child, as well as to evaluate outcomes for children whose mothers had preeclampsia during pregnancy.
The CHAP Maternal follow-up study is a follow-up to the previous Chronic Hypertension and Pregnancy (CHAP) Project trial (2015-2021), which evaluated the safety and benefits of treating chronic hypertension (CHTN), or high blood pressure during pregnancy, and showed that treatment improved outcomes for mother and baby.
This study is for people with chronic kidney disease who may have a genetic variation called APOL1, which can increase the risk of kidney problems. If you haven’t been tested before, you’ll get a blood test to check for this gene—if you have it, you may be able to join the full study to test a new treatment.
